In vivo evaluation of cholesterol 7 alpha-hydroxylation in humans: effect of disease and drug treatment. 1986

M Bertolotti, and N Carulli, and D Menozzi, and F Zironi, and A Digrisolo, and A Pinetti, and M G Baldini

7 alpha-Hydroxylation of cholesterol is a stereospecific reaction consisting of the replacement of the 7 alpha-hydrogen with a hydroxyl group. When cholesterol labeled with tritium at the 7 alpha position is administered, the hydroxylation of the substrate will result in the loss of tritium which in turn will label the body water. The rate of tritium enrichment of the body water could thus give a quantitative estimate of the hydroxylation rate. This study describes the validation of the procedure with some 21 studies performed on 15 subjects in different conditions. [7 alpha-3H]cholesterol was administered intravenously in 50 ml of plasma and thereafter blood was sampled at timed intervals for 4 to 5 days. The rate of the hydroxylation of cholesterol was calculated from the time course of the specific activities of plasma cholesterol and body water after tracer administration and was expressed as 7 alpha-hydroxycholesterol formed/24 hr. Calculated values of hydroxylation in three control subjects (493 +/- 206), five patients with hyperlipoproteinemia (539 +/- 168), and seven cirrhotic patients (153 +/- 136) are in good agreement with figures reported for bile acid synthesis determined with other techniques. Cholesterol 7 alpha-hydroxylation rate is reduced in patients with cirrhosis, the impairment being related to the severity of the disease. Cholestyramine administered to one subject for 4 weeks produced a threefold increase of the hydroxylation. Administration of chenodeoxycholic acid resulted in a 50% decrease, whereas that of ursodeoxycholic did not produce consistent changes of the hydroxylation rate. The results support the current view that 7 alpha-hydroxylation of cholesterol is rate-limiting in the synthesis of bile acids.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D006951 Hyperlipoproteinemias Conditions with abnormally elevated levels of LIPOPROTEINS in the blood. They may be inherited, acquired, primary, or secondary. Hyperlipoproteinemias are classified according to the pattern of lipoproteins on electrophoresis or ultracentrifugation. Hyperlipoproteinemia
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001834 Body Water Fluids composed mainly of water found within the body. Water, Body
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D002788 Cholesterol Esters Fatty acid esters of cholesterol which constitute about two-thirds of the cholesterol in the plasma. The accumulation of cholesterol esters in the arterial intima is a characteristic feature of atherosclerosis. Cholesterol Ester,Cholesteryl Ester,Cholesteryl Esters,Ester, Cholesterol,Ester, Cholesteryl,Esters, Cholesterol,Esters, Cholesteryl
D002790 Cholesterol 7-alpha-Hydroxylase A membrane-bound cytochrome P450 enzyme that catalyzes the 7-alpha-hydroxylation of CHOLESTEROL in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP7, converts cholesterol to 7-alpha-hydroxycholesterol which is the first and rate-limiting step in the synthesis of BILE ACIDS. CYP7,CYP7A,Cytochrome P-450 CYP7,CYP 7,CYP 7A,Cholesterol 7-alpha-Monooxygenase,Cholesterol 7alpha-Hydroxylase,Cholesterol-7-Hydroxylase,Cytochrome P450 7,Cholesterol 7 Hydroxylase,Cholesterol 7 alpha Hydroxylase,Cholesterol 7 alpha Monooxygenase,Cholesterol 7alpha Hydroxylase,Cytochrome P 450 CYP7
D005260 Female Females

Related Publications

M Bertolotti, and N Carulli, and D Menozzi, and F Zironi, and A Digrisolo, and A Pinetti, and M G Baldini
February 1974, Nihon Naibunpi Gakkai zasshi,
M Bertolotti, and N Carulli, and D Menozzi, and F Zironi, and A Digrisolo, and A Pinetti, and M G Baldini
January 1974, Atherosclerosis,
M Bertolotti, and N Carulli, and D Menozzi, and F Zironi, and A Digrisolo, and A Pinetti, and M G Baldini
September 1968, Journal of biochemistry,
M Bertolotti, and N Carulli, and D Menozzi, and F Zironi, and A Digrisolo, and A Pinetti, and M G Baldini
June 1975, The Biochemical journal,
M Bertolotti, and N Carulli, and D Menozzi, and F Zironi, and A Digrisolo, and A Pinetti, and M G Baldini
February 1980, Experimental and molecular pathology,
M Bertolotti, and N Carulli, and D Menozzi, and F Zironi, and A Digrisolo, and A Pinetti, and M G Baldini
April 1980, Steroids,
M Bertolotti, and N Carulli, and D Menozzi, and F Zironi, and A Digrisolo, and A Pinetti, and M G Baldini
January 1971, Archives internationales de physiologie et de biochimie,
M Bertolotti, and N Carulli, and D Menozzi, and F Zironi, and A Digrisolo, and A Pinetti, and M G Baldini
January 1984, Biology of the neonate,
M Bertolotti, and N Carulli, and D Menozzi, and F Zironi, and A Digrisolo, and A Pinetti, and M G Baldini
April 1993, Journal of lipid research,
M Bertolotti, and N Carulli, and D Menozzi, and F Zironi, and A Digrisolo, and A Pinetti, and M G Baldini
December 1974, Biochemical and biophysical research communications,
Copied contents to your clipboard!